CoChat
Sign Up
Cited by 317Platelet Disorders and TreatmentsChemokine receptors and signalingBlood Coagulation and Thrombosis Mechanisms

The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.

Platelet chemokines and chemokine receptors, linking hemostasis, inflammation, and host defense

GEAR, ADRIAN R.L., CAMERINI, DAVID·2003·Microcirculation
DOI 10.1038/sj.mn.7800198
Open this paper in CoChat — free account

Abstract

Blood platelets play critical roles in hemostasis, providing rapid essential protection against bleeding and catalyzing the important slower formation of stable blood clots via the coagulation cascade. They are also involved in protection from infection by phagocytosis of pathogens and by secreting chemokines that attract leukocytes. Platelet function usually is activated by primary agonists such as adenosine diphosphate (ADP), thrombin, and collagen, whereas secondary agonists like adrenalin do not induce aggregation on their own but become highly effective in the presence of low levels of primary agonists. Current research has revealed that chemokines represent an important additional class of agonists capable of causing significant activation of platelet function. Early work on platelet alpha-granule proteins suggested that platelet factor 4, now known as CXCL4, modulated aggregation and secretion induced by low agonist levels. Subsequent reports revealed the presence in platelets of messenger RNA for several additional chemokines and chemokine receptors. Three chemokines in particular, CXCL12 (SDF-1), CCL17 (TARC), and CCL22 (MDC), recently have been shown to be strong and rapid activators of platelet aggregation and adhesion after their binding to platelet CXCR4 or CCR4, when acting in combination with low levels of primary agonists. CXCL12 can be secreted by endothelial cells and is present in atherosclerotic plaques, whereas CCL17 and CCL22 are secreted by monocytes and macrophages. Platelet activation leads to the release of alpha-granule chemokines, including CCL3 (MIP-1alpha), CCL5 (RANTES), CCL7 (MCP-3), CCL17, CXCL1 (growth-regulated oncogene-alpha), CXCL5 (ENA-78), and CXCL8 (IL-8), which attract leukocytes and further activate other platelets. These findings help to provide a direct linkage between hemostasis, infection, and inflammation and the development of atherosclerosis.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.mn.7800198

Cites

164 of 164 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Cerletti C., 2002, Platelets in Thrombotic and Non‐Thrombotic Disorders: Patho‐physiology, Pharmacology and Therapeutics, 412431
  2. Dobroski DR, 1998, Thrombosis and Hemorrhage, 837
  3. Levine J., 1998, Thrombosis and Hemorrhage, 1065
  4. Peerschke EI, 1998, Thrombosis and Hemorrhage, 229

Cited by

Sorted by citations

See all 317

Related

See all

Metadata

Authors
GEAR, A. R. L., & CAMERINI, D.
Affiliations
University of Virginia (US)
Corresponding author
GEAR, ADRIAN R.L.
ORCID
CAMERINI, DAVID
Venue
Microcirculation
Publisher
Wiley
Published
2003-07
Volume
10
Issue
3-4
Pages
335-350
ISSN
  • 1073-9688 (ISSN-L)
  • 1549-8719
DOI
10.1038/sj.mn.7800198
OpenAlex
W2001798594
Cited by
317
References
161
Citations by year
2026: 4 · 2025: 4 · 2024: 10 · 2023: 4 · 2022: 10 · 2021: 13 · 2020: 13 · 2019: 7 · 2018: 10 · 2017: 13 · 2016: 17 · 2015: 28 · 2014: 18 · 2013: 6 · 2012: 21
FWCI
2.80
Type
journal article
Language
en
Open access
closed
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor, 2401 d)
Locations
  • Microcirculation (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (1r29ai039943-01a1)
  • National Institute of Allergy and Infectious Diseases (AI 39943)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK59004)
Topics
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
  • Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords
chemokine receptors, platelet activation, platelet aggregation, hemostasis, inflammation, host defense, CXCL12, CCL17, CCL22, CXCR4, CCR4, alpha-granule proteins, atherosclerosis, leukocyte recruitment, platelet factor 4, CCL3, RANTES, CCL7, interleukin-8
MeSH terms
Blood Platelets, Hemostasis, Humans, Immunity, Inflammation, Chemokines, Receptors, Chemokine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review